Animal Sedatives Market Analysis

Animal Sedatives Market Analysis

Based on drug class, the animal sedatives market is segmented into phenothiazines, alpha-2 adrenergic receptor agonists, benzodiazepines, butyrophenones, and other drug classes. In 2022, the phenothiazines segment accounted for the largest share of 39.4% in the industry. They provide sedation, muscle relaxation, and antiemetic effects in small animals. They are the most common and effective animal sedatives for cats and dogs. Acepromazine is one of the most widely used members of the phenothiazine class of sedatives. This class of drug can be administered orally or parenterally.

Based on route of administration, the animal sedatives market is subdivided into parenteral and oral. The parenteral segment is expected to showcase value at a CAGR of 5% by 2032. Parenteral administration of sedatives helps ensure a faster and more reliable absorption of the sedative into the bloodstream. It helps in the rapid onset of action and enables control over dosage for precise administration of sedatives. It enhances the bioavailability of sedatives, leading to higher and sufficient absorption of sedatives.
 

Based on application, the animal sedatives market is classified into surgical procedures, diagnostic procedures, clinical research studies and other applications. In 2022, surgical procedures segment was valued to be around USD 59.2 million. The sedatives are commonly used to facilitate animal surgical procedures in veterinary medicines. They help in reducing the anxiety and fear in animals making them manageable and ease to handle while performing the surgical procedures. They help to calm them and ensures safety of animals as well as the staff.
 

Based on animal type, the animal sedatives market is subdivided into small animals and large animals. The small animal segment is further subdivided into dogs, cats, and other small animals. The large animal segment is further subdivided into cattle, horses, and other large animals. The small animal segment comprised of the largest market share of 73.9%, in 2022. The key factors supporting the expansion of this segment are the rapidly increasing pet ownership, the high prevalence of zoonotic diseases, the increasing adoption of pet insurance, and the increasing need of diagnostics and adequate treatment.
 

Based on distribution channel, the animal sedatives market is classified into hospital pharmacies, retail pharmacies, and other distribution channels. The hospital pharmacies segment held the largest market share of 52.9% in 2022. The increasing prevalence of zoonotic diseases, the growing need of diagnostics, the increasing number of visits to veterinary hospitals and clinics, and the increasing number of veterinary practitioners.
 

Based on the region, In 2022, the North American animal sedatives market is expected to reach USD 103.4 million by 2032. This is because of a significant population of pets, well-established veterinary infrastructure, high utilization of animal sedatives for a wide range of applications, including diagnosis, surgical procedures, or animal handling, and increasing animal healthcare expenditure. On the other hand, the Asia Pacific industry is expected to grow at the highest CAGR of 6% by 2032.